Hassan, M.S. and Jawad, A.M. 2026. Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer. Middle Eastern Cancer and Oncology Journal. 2, 3 (Jul. 2026), 1–9. DOI:https://doi.org/10.61706/MECOJ160229.